Alnylam Pharmaceuticals
ALNY
#707
Rank
ยฃ26.66 B
Marketcap
ยฃ199.68
Share price
-1.61%
Change (1 day)
-16.64%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company